[Federal Register Volume 77, Number 40 (Wednesday, February 29, 2012)]
[Notices]
[Page 12318]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-4750]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2) notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The purpose of this meeting is to evaluate requests 
for development resources for potential new cancer diagnostics. The 
outcome of the evaluation will provide information for consideration by 
an internal NCI committee that will decide whether NCI/DCTD should 
support requests and make available contract resources for development 
of the potential diagnostics to improve the treatment of cancer. The 
research proposals and the discussions could disclose confidential 
trade secrets or commercial property such as patentable material and 
personal information concerning individuals associated with the 
proposed research projects, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Clinical Assay Development Program (CADP).
    Date: April 10, 2012.
    Time: 8 a.m.-4 p.m.
    Agenda: To evaluate requests for development resources for 
potential new diagnostics for cancer.
    Place: National Cancer Institute, NIH, 6001 Executive Boulevard, 
Room C, Rockville, MD 20852.
    Contact Person: Tracy G. Lively, Ph.D., Executive Secretary, 
Clinical Assay Development Program (CADP), National Cancer 
Institute, NIH, 6130 Executive Boulevard, EPN/6042, Bethesda, MD 
20892, 301-496-1591, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 22, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-4750 Filed 2-28-12; 8:45 am]
BILLING CODE 4140-01-P